Patents Assigned to Inhibikase Therapeutics, Inc.
  • Compositions and methods for inhibiting kinases
    Patent number: 11725005
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: August 15, 2023
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 11407747
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: August 9, 2022
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10906896
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: February 2, 2021
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10344027
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: July 9, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10316031
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: June 11, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compositions and methods for inhibiting kinases
    Patent number: 10118923
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: November 6, 2018
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Methods of treating tumoral diseases, or bacterial or viral infections
    Patent number: 9907796
    Abstract: Novel compounds and their synthesis are described. Methods for using these compounds in the prevention or treatment of cancer, a bacterial infection or a viral infection in a subject are also described.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: March 6, 2018
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Rhushikesh Chandrabhan Deokar, Sundeep Dugar, Dinesh Mahajan, Milton Henry Werner
  • Compositions and methods for inhibiting kinases
    Patent number: 9828370
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: November 28, 2017
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Compounds and compositions thereof
    Patent number: 9487500
    Abstract: Novel compounds and their synthesis are described. Methods for using these compounds in the prevention or treatment of cancer, a bacterial infection or a viral infection in a subject are also described.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: November 8, 2016
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Rhushikesh C. Deokar, Sundeep H. Dugar, Dinesh Mahajan, Milton H. Werner
  • METHODS FOR TREATING HCV INFECTION
    Publication number: 20160101106
    Abstract: The present invention provides methods of treating HCV infection in subjects (e.g., mammals), comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor or a prodrug thereof. The present invention also provides methods of treating HCV infection, comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor conjointly with at least one additional therapeutic agent (e.g., an antiviral agent).
    Type: Application
    Filed: May 6, 2014
    Publication date: April 14, 2016
    Applicant: Inhibikase Therapeutics, Inc.
    Inventor: Milton H Werner
  • NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES
    Publication number: 20140100225
    Abstract: Novel compounds and their synthesis are described. Methods for using these compounds in the prevention or treatment of cancer, a bacterial infection or a viral infection in a subject are also described.
    Type: Application
    Filed: October 4, 2013
    Publication date: April 10, 2014
    Applicants: Inhibikase Therapeutics, Inc., Sphaera Pharma Pvt. Ltd., Sphaera Pharma Pte. Ltd.
    Inventors: Rhushikesh Chandrabhan Deokar, Sundeep Dugar, Dinesh Mahajan, Milton Henry Werner